Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Wounds, Nonpenetrating | 3 | 2010 | 793 | 0.480 |
Why?
|
Warfarin | 12 | 2009 | 1518 | 0.340 |
Why?
|
Abdominal Injuries | 1 | 2009 | 359 | 0.260 |
Why?
|
Smoking Cessation | 8 | 2009 | 2064 | 0.260 |
Why?
|
Spleen | 1 | 2010 | 2298 | 0.230 |
Why?
|
Neuromuscular Nondepolarizing Agents | 3 | 2002 | 144 | 0.230 |
Why?
|
Videotape Recording | 3 | 2009 | 337 | 0.230 |
Why?
|
Atrial Fibrillation | 13 | 2009 | 5209 | 0.230 |
Why?
|
Anticoagulants | 13 | 2009 | 4897 | 0.220 |
Why?
|
Renal Dialysis | 6 | 2009 | 1801 | 0.210 |
Why?
|
Medical Order Entry Systems | 1 | 2007 | 522 | 0.200 |
Why?
|
Spinal Stenosis | 1 | 2005 | 262 | 0.200 |
Why?
|
Thromboembolism | 7 | 2009 | 1017 | 0.190 |
Why?
|
Guideline Adherence | 3 | 2007 | 2283 | 0.190 |
Why?
|
Smoking | 9 | 2009 | 9073 | 0.160 |
Why?
|
Intracranial Hemorrhages | 5 | 2009 | 844 | 0.160 |
Why?
|
Nasal Septum | 1 | 2000 | 130 | 0.160 |
Why?
|
Anesthesia Recovery Period | 2 | 2007 | 155 | 0.150 |
Why?
|
Cerebral Hemorrhage | 6 | 2008 | 2660 | 0.150 |
Why?
|
Data Collection | 3 | 2010 | 3315 | 0.150 |
Why?
|
Nasal Obstruction | 1 | 2000 | 159 | 0.150 |
Why?
|
Gatekeeping | 3 | 2002 | 49 | 0.150 |
Why?
|
AIDS Serodiagnosis | 2 | 2009 | 216 | 0.150 |
Why?
|
Female | 122 | 2010 | 391270 | 0.140 |
Why?
|
Aged | 77 | 2010 | 169152 | 0.140 |
Why?
|
Prospective Studies | 33 | 2009 | 54303 | 0.140 |
Why?
|
Angina, Unstable | 3 | 2006 | 926 | 0.140 |
Why?
|
Middle Aged | 82 | 2010 | 220352 | 0.140 |
Why?
|
Male | 107 | 2010 | 359744 | 0.140 |
Why?
|
Colonic Diseases | 1 | 1998 | 200 | 0.140 |
Why?
|
New England | 2 | 2010 | 1050 | 0.140 |
Why?
|
Managed Care Programs | 4 | 2007 | 939 | 0.140 |
Why?
|
Retrospective Studies | 40 | 2010 | 80372 | 0.130 |
Why?
|
Stroke | 14 | 2010 | 9962 | 0.130 |
Why?
|
Specialization | 4 | 2008 | 778 | 0.130 |
Why?
|
Operating Rooms | 3 | 2007 | 789 | 0.130 |
Why?
|
Adult | 78 | 2010 | 219994 | 0.130 |
Why?
|
Bupropion | 2 | 2008 | 304 | 0.120 |
Why?
|
Trauma Centers | 3 | 2010 | 933 | 0.120 |
Why?
|
Sciatica | 3 | 2006 | 97 | 0.120 |
Why?
|
Recovery Room | 3 | 2006 | 34 | 0.120 |
Why?
|
Cerebral Infarction | 5 | 2003 | 982 | 0.120 |
Why?
|
Workers' Compensation | 3 | 2006 | 150 | 0.120 |
Why?
|
Humans | 150 | 2010 | 760621 | 0.120 |
Why?
|
Isoquinolines | 3 | 2002 | 353 | 0.120 |
Why?
|
Fertilization in Vitro | 5 | 2001 | 1292 | 0.110 |
Why?
|
Neurofibroma, Plexiform | 2 | 2005 | 66 | 0.110 |
Why?
|
Terminal Care | 3 | 2009 | 1758 | 0.110 |
Why?
|
Anesthesia, Local | 2 | 2006 | 276 | 0.110 |
Why?
|
Aged, 80 and over | 36 | 2009 | 58995 | 0.110 |
Why?
|
Aminolevulinic Acid | 2 | 2006 | 142 | 0.110 |
Why?
|
Hospital Costs | 3 | 2008 | 976 | 0.100 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2009 | 265 | 0.100 |
Why?
|
Medicine | 4 | 2008 | 943 | 0.100 |
Why?
|
Logistic Models | 19 | 2009 | 13314 | 0.100 |
Why?
|
Recovery of Function | 5 | 2009 | 2985 | 0.100 |
Why?
|
Pancreatitis | 3 | 2008 | 1100 | 0.100 |
Why?
|
Brain Ischemia | 5 | 2010 | 3127 | 0.100 |
Why?
|
Decision Making | 4 | 2009 | 3925 | 0.100 |
Why?
|
Advance Care Planning | 2 | 2009 | 697 | 0.100 |
Why?
|
Academic Medical Centers | 5 | 2009 | 2754 | 0.100 |
Why?
|
Counseling | 4 | 2009 | 1548 | 0.100 |
Why?
|
Trauma Severity Indices | 2 | 2010 | 478 | 0.100 |
Why?
|
Kidney Failure, Chronic | 3 | 2008 | 2471 | 0.100 |
Why?
|
Physicians, Women | 2 | 2008 | 495 | 0.090 |
Why?
|
Family Practice | 3 | 2005 | 510 | 0.090 |
Why?
|
Cohort Studies | 22 | 2010 | 41335 | 0.090 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 680 | 0.090 |
Why?
|
Lumbar Vertebrae | 3 | 2006 | 1868 | 0.090 |
Why?
|
Prenatal Care | 3 | 2008 | 1129 | 0.090 |
Why?
|
Phosphorus | 2 | 2008 | 333 | 0.090 |
Why?
|
Hospital Units | 2 | 2008 | 142 | 0.090 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 1999 | 47 | 0.080 |
Why?
|
Predictive Value of Tests | 18 | 2009 | 15289 | 0.080 |
Why?
|
Cholecystectomy | 2 | 2008 | 406 | 0.080 |
Why?
|
Time Management | 2 | 2006 | 52 | 0.080 |
Why?
|
Emergency Service, Hospital | 7 | 2007 | 7818 | 0.080 |
Why?
|
Lidocaine | 2 | 2005 | 538 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2009 | 2001 | 0.080 |
Why?
|
Health Maintenance Organizations | 2 | 2002 | 660 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2009 | 2852 | 0.080 |
Why?
|
Creatine Kinase, MB Form | 2 | 2008 | 211 | 0.080 |
Why?
|
Gelsolin | 1 | 2009 | 189 | 0.080 |
Why?
|
Multivariate Analysis | 11 | 2009 | 12159 | 0.080 |
Why?
|
Splenectomy | 1 | 2010 | 391 | 0.080 |
Why?
|
Proxy | 1 | 2009 | 148 | 0.080 |
Why?
|
Patient Education as Topic | 3 | 2008 | 2315 | 0.080 |
Why?
|
Air Ambulances | 1 | 2009 | 92 | 0.080 |
Why?
|
Risk Factors | 22 | 2010 | 74359 | 0.080 |
Why?
|
Patient Satisfaction | 5 | 2009 | 3448 | 0.080 |
Why?
|
Antibodies, Anticardiolipin | 2 | 1999 | 62 | 0.080 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2009 | 138 | 0.070 |
Why?
|
Ovarian Follicle | 2 | 2001 | 244 | 0.070 |
Why?
|
Postpartum Period | 3 | 2009 | 1167 | 0.070 |
Why?
|
Kidney Diseases | 2 | 2009 | 2093 | 0.070 |
Why?
|
Community-Acquired Infections | 3 | 2001 | 461 | 0.070 |
Why?
|
Diverticulitis | 1 | 2010 | 182 | 0.070 |
Why?
|
Early Ambulation | 1 | 2007 | 49 | 0.070 |
Why?
|
Prostatic Hyperplasia | 3 | 1996 | 530 | 0.070 |
Why?
|
Piperidines | 2 | 2009 | 1650 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 2 | 2003 | 786 | 0.070 |
Why?
|
Patient Care Management | 2 | 2007 | 303 | 0.070 |
Why?
|
Photochemotherapy | 2 | 2006 | 820 | 0.070 |
Why?
|
Patient Admission | 2 | 2008 | 1386 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 1998 | 2526 | 0.070 |
Why?
|
Treatment Failure | 2 | 2010 | 2648 | 0.070 |
Why?
|
Nicotine | 2 | 2009 | 677 | 0.070 |
Why?
|
Postanesthesia Nursing | 1 | 2006 | 10 | 0.070 |
Why?
|
Nitrogen Radioisotopes | 1 | 2006 | 41 | 0.070 |
Why?
|
Workload | 3 | 2007 | 847 | 0.070 |
Why?
|
Coronary Disease | 4 | 2005 | 5990 | 0.070 |
Why?
|
Twins | 1 | 2008 | 339 | 0.070 |
Why?
|
Pyrazoles | 2 | 2009 | 1999 | 0.070 |
Why?
|
Women | 1 | 2008 | 225 | 0.070 |
Why?
|
Hematoporphyrin Photoradiation | 1 | 2005 | 17 | 0.070 |
Why?
|
Proteinuria | 1 | 2009 | 594 | 0.070 |
Why?
|
Spinal Injuries | 1 | 2009 | 300 | 0.070 |
Why?
|
Emergency Medicine | 2 | 2005 | 1196 | 0.070 |
Why?
|
Acute Disease | 9 | 2010 | 7269 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2009 | 3465 | 0.070 |
Why?
|
Periodicals as Topic | 2 | 2008 | 1469 | 0.070 |
Why?
|
HIV Infections | 5 | 2010 | 17165 | 0.070 |
Why?
|
Maternal Behavior | 1 | 2008 | 306 | 0.070 |
Why?
|
Treatment Outcome | 23 | 2009 | 65017 | 0.060 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 2006 | 58 | 0.060 |
Why?
|
Length of Stay | 7 | 2009 | 6479 | 0.060 |
Why?
|
Gallstones | 1 | 2008 | 283 | 0.060 |
Why?
|
Injury Severity Score | 1 | 2009 | 1033 | 0.060 |
Why?
|
Bronchoconstriction | 1 | 2006 | 139 | 0.060 |
Why?
|
Myocardial Infarction | 5 | 2008 | 11891 | 0.060 |
Why?
|
Myoglobin | 1 | 2005 | 159 | 0.060 |
Why?
|
Nitric Oxide | 2 | 2004 | 2141 | 0.060 |
Why?
|
Anesthetics, Local | 2 | 2005 | 1001 | 0.060 |
Why?
|
Police | 1 | 2007 | 156 | 0.060 |
Why?
|
Physical Exertion | 1 | 2008 | 662 | 0.060 |
Why?
|
Adolescent | 24 | 2009 | 87810 | 0.060 |
Why?
|
Massachusetts | 10 | 2010 | 8803 | 0.060 |
Why?
|
Steroids | 2 | 2002 | 928 | 0.060 |
Why?
|
Boston | 9 | 2010 | 9280 | 0.060 |
Why?
|
Postoperative Complications | 8 | 2010 | 15697 | 0.060 |
Why?
|
Afferent Pathways | 1 | 2006 | 299 | 0.060 |
Why?
|
Extinction, Psychological | 1 | 2008 | 371 | 0.060 |
Why?
|
Diagnostic Errors | 2 | 2009 | 1266 | 0.060 |
Why?
|
Angina Pectoris | 2 | 2005 | 969 | 0.060 |
Why?
|
Brachial Plexus | 1 | 2006 | 166 | 0.060 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2004 | 94 | 0.060 |
Why?
|
Depression, Postpartum | 1 | 2009 | 345 | 0.060 |
Why?
|
Abdomen | 2 | 2008 | 1130 | 0.060 |
Why?
|
Physicians, Family | 1 | 2006 | 349 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2009 | 622 | 0.060 |
Why?
|
Embryo Transfer | 2 | 1999 | 522 | 0.060 |
Why?
|
Carbon Monoxide | 2 | 2004 | 540 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2006 | 371 | 0.060 |
Why?
|
Cholinesterases | 2 | 2002 | 32 | 0.060 |
Why?
|
Utilization Review | 2 | 2002 | 383 | 0.060 |
Why?
|
Aspirin | 4 | 2004 | 3364 | 0.060 |
Why?
|
Photosensitizing Agents | 3 | 2006 | 618 | 0.060 |
Why?
|
Wounds and Injuries | 2 | 2009 | 2477 | 0.060 |
Why?
|
Medical Records | 3 | 2005 | 1407 | 0.060 |
Why?
|
Ambulatory Care | 3 | 2000 | 2781 | 0.060 |
Why?
|
Vitamin D | 2 | 2008 | 3291 | 0.060 |
Why?
|
Anti-HIV Agents | 2 | 2010 | 4491 | 0.060 |
Why?
|
Connective Tissue Diseases | 2 | 1997 | 286 | 0.060 |
Why?
|
Colectomy | 1 | 2009 | 692 | 0.060 |
Why?
|
Neurites | 1 | 2006 | 390 | 0.060 |
Why?
|
Hospital Information Systems | 1 | 2006 | 394 | 0.060 |
Why?
|
Adenocarcinoma | 5 | 2001 | 6315 | 0.060 |
Why?
|
Spinal Cord | 2 | 2003 | 1817 | 0.060 |
Why?
|
Ovarian Neoplasms | 4 | 2005 | 4878 | 0.060 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 489 | 0.060 |
Why?
|
Follicle Stimulating Hormone | 3 | 2001 | 725 | 0.060 |
Why?
|
Blood Flow Velocity | 3 | 2003 | 1377 | 0.060 |
Why?
|
Porphyrins | 1 | 2005 | 353 | 0.050 |
Why?
|
Sensitivity and Specificity | 9 | 2008 | 14660 | 0.050 |
Why?
|
Mass Screening | 3 | 2009 | 5423 | 0.050 |
Why?
|
Respiratory Function Tests | 1 | 2008 | 1683 | 0.050 |
Why?
|
Authorship | 1 | 2006 | 281 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 2 | 2010 | 1191 | 0.050 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 978 | 0.050 |
Why?
|
Bronchiolitis Obliterans | 1 | 2004 | 213 | 0.050 |
Why?
|
Autonomic Nerve Block | 1 | 2003 | 81 | 0.050 |
Why?
|
Ancillary Services, Hospital | 1 | 2002 | 23 | 0.050 |
Why?
|
Malpractice | 1 | 2008 | 556 | 0.050 |
Why?
|
Patients | 1 | 2009 | 906 | 0.050 |
Why?
|
Disability Evaluation | 2 | 2008 | 1826 | 0.050 |
Why?
|
Alfentanil | 1 | 2002 | 27 | 0.050 |
Why?
|
Neurofibromatosis 1 | 2 | 2005 | 560 | 0.050 |
Why?
|
Bibliometrics | 1 | 2006 | 351 | 0.050 |
Why?
|
Anesthetics, Combined | 1 | 2002 | 43 | 0.050 |
Why?
|
Triage | 1 | 2009 | 987 | 0.050 |
Why?
|
Fibrinolytic Agents | 4 | 2009 | 2167 | 0.050 |
Why?
|
Clostridium Infections | 1 | 2009 | 557 | 0.050 |
Why?
|
Focus Groups | 1 | 2008 | 1378 | 0.050 |
Why?
|
Digestive System Surgical Procedures | 1 | 2007 | 575 | 0.050 |
Why?
|
Nerve Fibers | 1 | 2006 | 708 | 0.050 |
Why?
|
Longitudinal Studies | 5 | 2009 | 14495 | 0.050 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2003 | 121 | 0.050 |
Why?
|
Pregnant Women | 1 | 2007 | 563 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 8 | 2009 | 20509 | 0.050 |
Why?
|
Mental Recall | 1 | 2008 | 1206 | 0.050 |
Why?
|
Community Health Services | 1 | 2007 | 654 | 0.050 |
Why?
|
Anesthesia, Intravenous | 1 | 2002 | 131 | 0.050 |
Why?
|
Physical Examination | 1 | 2008 | 1244 | 0.050 |
Why?
|
Accidents, Traffic | 1 | 2007 | 814 | 0.050 |
Why?
|
Actins | 1 | 2009 | 2049 | 0.050 |
Why?
|
Interdisciplinary Communication | 1 | 2007 | 934 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2004 | 933 | 0.050 |
Why?
|
Low Back Pain | 3 | 2005 | 979 | 0.050 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2002 | 128 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2010 | 1894 | 0.050 |
Why?
|
Odds Ratio | 7 | 2009 | 9716 | 0.050 |
Why?
|
Weight Gain | 2 | 2009 | 2347 | 0.050 |
Why?
|
Troponin I | 1 | 2005 | 638 | 0.050 |
Why?
|
Carcinoma | 2 | 2005 | 2331 | 0.050 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2000 | 21 | 0.050 |
Why?
|
Quality Assurance, Health Care | 2 | 2001 | 2176 | 0.050 |
Why?
|
International Cooperation | 1 | 2007 | 1433 | 0.050 |
Why?
|
Efficiency, Organizational | 1 | 2006 | 697 | 0.050 |
Why?
|
Hemorrhage | 4 | 2007 | 3600 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2007 | 1392 | 0.050 |
Why?
|
Dental Restoration Failure | 1 | 2001 | 155 | 0.050 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2005 | 586 | 0.050 |
Why?
|
Endometrial Neoplasms | 2 | 2001 | 1357 | 0.050 |
Why?
|
Coronary Care Units | 1 | 2002 | 235 | 0.050 |
Why?
|
Diet, Atherogenic | 1 | 2000 | 93 | 0.050 |
Why?
|
Follow-Up Studies | 14 | 2009 | 39261 | 0.050 |
Why?
|
Diagnosis, Differential | 6 | 2003 | 12965 | 0.050 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2006 | 465 | 0.050 |
Why?
|
Obstetrics | 1 | 2008 | 667 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 841 | 0.050 |
Why?
|
Electrosurgery | 1 | 2000 | 51 | 0.050 |
Why?
|
Viral Load | 1 | 2010 | 3322 | 0.050 |
Why?
|
Prostatic Neoplasms | 3 | 2009 | 11345 | 0.050 |
Why?
|
Injections, Epidural | 1 | 2002 | 200 | 0.050 |
Why?
|
Publishing | 1 | 2008 | 836 | 0.050 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 638 | 0.040 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5397 | 0.040 |
Why?
|
Prostatectomy | 1 | 2009 | 1956 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2009 | 2180 | 0.040 |
Why?
|
Uterine Cervical Diseases | 1 | 2000 | 74 | 0.040 |
Why?
|
Physician-Patient Relations | 4 | 2008 | 3242 | 0.040 |
Why?
|
Graft Rejection | 2 | 2004 | 4426 | 0.040 |
Why?
|
Epinephrine | 2 | 2005 | 791 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2004 | 978 | 0.040 |
Why?
|
Osseointegration | 1 | 2001 | 274 | 0.040 |
Why?
|
Cholecystitis | 1 | 2001 | 181 | 0.040 |
Why?
|
Survival Analysis | 7 | 2009 | 10182 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2006 | 708 | 0.040 |
Why?
|
Ultraviolet Therapy | 1 | 2000 | 84 | 0.040 |
Why?
|
Pylorus | 1 | 2000 | 86 | 0.040 |
Why?
|
Pancreaticoduodenectomy | 2 | 2001 | 508 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1067 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 2000 | 138 | 0.040 |
Why?
|
Burns | 2 | 2002 | 1866 | 0.040 |
Why?
|
Glycoproteins | 2 | 1997 | 2208 | 0.040 |
Why?
|
Patch Tests | 1 | 1999 | 57 | 0.040 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2000 | 104 | 0.040 |
Why?
|
Frozen Sections | 1 | 2000 | 153 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 1717 | 0.040 |
Why?
|
Vitamins | 1 | 2008 | 1634 | 0.040 |
Why?
|
Methotrexate | 1 | 2006 | 1719 | 0.040 |
Why?
|
Postoperative Care | 1 | 2006 | 1479 | 0.040 |
Why?
|
Age Factors | 9 | 2009 | 18416 | 0.040 |
Why?
|
Nerve Block | 1 | 2006 | 688 | 0.040 |
Why?
|
Dermatitis, Contact | 1 | 1999 | 133 | 0.040 |
Why?
|
Tyrosine | 1 | 2003 | 1438 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2145 | 0.040 |
Why?
|
California | 3 | 2009 | 1416 | 0.040 |
Why?
|
Time Factors | 13 | 2008 | 40165 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2002 | 397 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 8 | 2010 | 36290 | 0.040 |
Why?
|
Peritoneal Neoplasms | 1 | 2005 | 707 | 0.040 |
Why?
|
Analgesia, Epidural | 1 | 2002 | 330 | 0.040 |
Why?
|
Oocytes | 3 | 1998 | 1165 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2009 | 1779 | 0.040 |
Why?
|
Unnecessary Procedures | 1 | 2002 | 413 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1131 | 0.040 |
Why?
|
Antibodies, Antiphospholipid | 1 | 1999 | 71 | 0.040 |
Why?
|
Pulmonary Artery | 2 | 2004 | 1921 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 3 | 2009 | 2569 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2001 | 219 | 0.040 |
Why?
|
Microcirculation | 1 | 2003 | 1278 | 0.040 |
Why?
|
Vasospasm, Intracranial | 1 | 2001 | 215 | 0.040 |
Why?
|
Patient Care Team | 2 | 2007 | 2511 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2003 | 3164 | 0.040 |
Why?
|
Leadership | 1 | 2008 | 1371 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2001 | 319 | 0.040 |
Why?
|
Ultrasonography | 6 | 2003 | 5961 | 0.040 |
Why?
|
Mothers | 1 | 2009 | 2186 | 0.040 |
Why?
|
Endosonography | 1 | 2002 | 607 | 0.040 |
Why?
|
Cardiac Output | 1 | 2001 | 838 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1106 | 0.040 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 1997 | 288 | 0.040 |
Why?
|
Ovarian Cysts | 1 | 1999 | 108 | 0.040 |
Why?
|
Survival Rate | 7 | 2009 | 12808 | 0.040 |
Why?
|
Colitis, Ischemic | 1 | 1998 | 32 | 0.040 |
Why?
|
Severity of Illness Index | 8 | 2009 | 15840 | 0.040 |
Why?
|
Employment | 2 | 2006 | 1112 | 0.040 |
Why?
|
Patient Selection | 2 | 2008 | 4283 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2001 | 485 | 0.040 |
Why?
|
Pancuronium | 1 | 1997 | 44 | 0.040 |
Why?
|
Tubocurarine | 1 | 1997 | 62 | 0.040 |
Why?
|
Vecuronium Bromide | 1 | 1997 | 33 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2006 | 1192 | 0.040 |
Why?
|
Pregnancy Rate | 2 | 1999 | 649 | 0.040 |
Why?
|
Serotonin Antagonists | 1 | 1998 | 144 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 2529 | 0.040 |
Why?
|
Atracurium | 1 | 1997 | 52 | 0.040 |
Why?
|
Heart Rate | 1 | 2009 | 4179 | 0.040 |
Why?
|
Critical Pathways | 1 | 2001 | 475 | 0.040 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2009 | 1459 | 0.040 |
Why?
|
Axons | 1 | 2006 | 1673 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1721 | 0.040 |
Why?
|
Vitamin D Deficiency | 1 | 2007 | 1379 | 0.040 |
Why?
|
Virilism | 1 | 1997 | 28 | 0.040 |
Why?
|
Esophagectomy | 1 | 2001 | 466 | 0.040 |
Why?
|
Ondansetron | 1 | 1998 | 95 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1999 | 238 | 0.040 |
Why?
|
Diethylstilbestrol | 1 | 1997 | 88 | 0.040 |
Why?
|
Estrogens, Non-Steroidal | 1 | 1997 | 52 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2003 | 613 | 0.040 |
Why?
|
Pneumonia | 2 | 2000 | 2131 | 0.040 |
Why?
|
Hypotension | 1 | 2003 | 883 | 0.040 |
Why?
|
Antiphospholipid Syndrome | 1 | 1999 | 165 | 0.040 |
Why?
|
Pregnancy | 11 | 2009 | 29749 | 0.040 |
Why?
|
Hydronephrosis | 1 | 1998 | 271 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1630 | 0.040 |
Why?
|
Inhibins | 1 | 1997 | 209 | 0.040 |
Why?
|
Abdominal Pain | 1 | 2003 | 1063 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2001 | 901 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2007 | 3562 | 0.030 |
Why?
|
International Normalized Ratio | 3 | 2004 | 386 | 0.030 |
Why?
|
Testicular Hormones | 1 | 1997 | 188 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2571 | 0.030 |
Why?
|
Health Policy | 1 | 2009 | 2677 | 0.030 |
Why?
|
Diverticulitis, Colonic | 1 | 1998 | 138 | 0.030 |
Why?
|
Ureteral Obstruction | 1 | 1998 | 292 | 0.030 |
Why?
|
Gonadotropins | 1 | 1997 | 241 | 0.030 |
Why?
|
Antiemetics | 1 | 1998 | 187 | 0.030 |
Why?
|
Tobacco Industry | 1 | 1997 | 135 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2001 | 810 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2009 | 20080 | 0.030 |
Why?
|
Cryptorchidism | 1 | 1997 | 151 | 0.030 |
Why?
|
Child, Preschool | 9 | 2009 | 42063 | 0.030 |
Why?
|
Ascites | 1 | 1998 | 338 | 0.030 |
Why?
|
Propofol | 1 | 2002 | 608 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2002 | 901 | 0.030 |
Why?
|
Tissue and Organ Procurement | 1 | 2004 | 944 | 0.030 |
Why?
|
Growth Inhibitors | 1 | 1997 | 378 | 0.030 |
Why?
|
Prognosis | 9 | 2010 | 29658 | 0.030 |
Why?
|
Child Health Services | 1 | 2001 | 644 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2001 | 1516 | 0.030 |
Why?
|
Risk Assessment | 5 | 2009 | 24123 | 0.030 |
Why?
|
General Surgery | 1 | 2007 | 1678 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2008 | 5125 | 0.030 |
Why?
|
Mandible | 1 | 2000 | 750 | 0.030 |
Why?
|
Pancreas | 1 | 2002 | 1677 | 0.030 |
Why?
|
Health Status Indicators | 2 | 2003 | 968 | 0.030 |
Why?
|
Growth Substances | 1 | 1997 | 768 | 0.030 |
Why?
|
Interviews as Topic | 2 | 2009 | 2659 | 0.030 |
Why?
|
Confidence Intervals | 3 | 2008 | 2932 | 0.030 |
Why?
|
Blood Pressure | 2 | 2008 | 8525 | 0.030 |
Why?
|
Nausea | 1 | 1998 | 678 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2004 | 1305 | 0.030 |
Why?
|
Case-Control Studies | 7 | 2009 | 22053 | 0.030 |
Why?
|
Acne Vulgaris | 1 | 2000 | 355 | 0.030 |
Why?
|
Gastrectomy | 1 | 2000 | 679 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2000 | 758 | 0.030 |
Why?
|
Vomiting | 1 | 1998 | 650 | 0.030 |
Why?
|
Health Status | 2 | 2000 | 4081 | 0.030 |
Why?
|
Estrogens | 1 | 2001 | 1520 | 0.030 |
Why?
|
Glioma | 1 | 2009 | 3420 | 0.030 |
Why?
|
Office Visits | 1 | 1999 | 597 | 0.030 |
Why?
|
Health Promotion | 1 | 2007 | 2206 | 0.030 |
Why?
|
Dementia | 1 | 2009 | 2649 | 0.030 |
Why?
|
Child | 13 | 2009 | 79806 | 0.030 |
Why?
|
Infant | 7 | 2009 | 36060 | 0.030 |
Why?
|
Anesthesia, General | 2 | 2002 | 1166 | 0.030 |
Why?
|
United States | 14 | 2009 | 72461 | 0.030 |
Why?
|
Kidney Calculi | 1 | 1998 | 468 | 0.030 |
Why?
|
Peroxidase | 1 | 1997 | 605 | 0.030 |
Why?
|
Program Evaluation | 2 | 2002 | 2493 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2001 | 1014 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2009 | 6544 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4446 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1570 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2000 | 1155 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2000 | 698 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3986 | 0.030 |
Why?
|
Fever | 1 | 2001 | 1617 | 0.030 |
Why?
|
Quality of Life | 3 | 2006 | 13308 | 0.030 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2001 | 1032 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 1995 | 279 | 0.030 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1997 | 377 | 0.030 |
Why?
|
Primary Health Care | 4 | 2005 | 4647 | 0.030 |
Why?
|
Dental Implants | 1 | 2001 | 791 | 0.030 |
Why?
|
Exercise Test | 1 | 2001 | 2128 | 0.030 |
Why?
|
Telephone | 2 | 2007 | 624 | 0.030 |
Why?
|
Laser Therapy | 1 | 2000 | 1089 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2003 | 3201 | 0.030 |
Why?
|
Young Adult | 5 | 2010 | 58741 | 0.030 |
Why?
|
Autoantigens | 1 | 1997 | 877 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2001 | 1878 | 0.030 |
Why?
|
Infusions, Intravenous | 3 | 2004 | 2234 | 0.030 |
Why?
|
Health Care Costs | 2 | 2008 | 3258 | 0.030 |
Why?
|
Regression Analysis | 4 | 2007 | 6360 | 0.030 |
Why?
|
Aorta | 1 | 2000 | 2039 | 0.030 |
Why?
|
Triglycerides | 1 | 2000 | 2476 | 0.030 |
Why?
|
World Health Organization | 2 | 2009 | 1312 | 0.030 |
Why?
|
Absorption | 2 | 2005 | 243 | 0.030 |
Why?
|
Pyridines | 1 | 2004 | 2879 | 0.030 |
Why?
|
Postmenopause | 1 | 2001 | 2509 | 0.030 |
Why?
|
Comorbidity | 4 | 2009 | 10551 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3865 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2004 | 2325 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2001 | 2108 | 0.030 |
Why?
|
Infertility, Female | 1 | 1998 | 759 | 0.030 |
Why?
|
Skin | 1 | 2006 | 4466 | 0.020 |
Why?
|
Immunotherapy | 2 | 2005 | 4642 | 0.020 |
Why?
|
Rheumatic Diseases | 1 | 1999 | 639 | 0.020 |
Why?
|
Patient Preference | 2 | 2009 | 922 | 0.020 |
Why?
|
Single-Blind Method | 3 | 2002 | 1578 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 1997 | 1021 | 0.020 |
Why?
|
Intestine, Small | 1 | 1998 | 1207 | 0.020 |
Why?
|
Cost Savings | 1 | 1997 | 920 | 0.020 |
Why?
|
Psoriasis | 1 | 2000 | 940 | 0.020 |
Why?
|
Sheep | 2 | 2004 | 1441 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1925 | 0.020 |
Why?
|
Stents | 1 | 2003 | 3314 | 0.020 |
Why?
|
Occupational Diseases | 1 | 2000 | 1486 | 0.020 |
Why?
|
Memory | 1 | 2001 | 2179 | 0.020 |
Why?
|
Cholesterol | 1 | 2000 | 2924 | 0.020 |
Why?
|
Chronic Disease | 5 | 2009 | 9287 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2001 | 1648 | 0.020 |
Why?
|
Thigh | 2 | 2005 | 240 | 0.020 |
Why?
|
Lipectomy | 2 | 2005 | 112 | 0.020 |
Why?
|
Heart Diseases | 2 | 2001 | 2809 | 0.020 |
Why?
|
Brain | 3 | 2010 | 26951 | 0.020 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2000 | 1223 | 0.020 |
Why?
|
Incidence | 6 | 2007 | 21392 | 0.020 |
Why?
|
Epidural Space | 2 | 2002 | 122 | 0.020 |
Why?
|
Double-Blind Method | 4 | 2009 | 12427 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2001 | 2907 | 0.020 |
Why?
|
Recurrence | 3 | 2009 | 8482 | 0.020 |
Why?
|
Pilot Projects | 4 | 2007 | 8555 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2002 | 2782 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2008 | 4555 | 0.020 |
Why?
|
Group Practice, Prepaid | 2 | 2001 | 15 | 0.020 |
Why?
|
Reoperation | 1 | 2000 | 4291 | 0.020 |
Why?
|
Endometriosis | 1 | 1998 | 874 | 0.020 |
Why?
|
Pain Measurement | 3 | 2008 | 3528 | 0.020 |
Why?
|
Myocardium | 1 | 2002 | 4700 | 0.020 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2009 | 29 | 0.020 |
Why?
|
Drug Costs | 1 | 1997 | 1185 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2002 | 2299 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 1997 | 1175 | 0.020 |
Why?
|
Consent Forms | 1 | 2009 | 55 | 0.020 |
Why?
|
Causality | 2 | 2008 | 1242 | 0.020 |
Why?
|
Leukopenia | 1 | 2009 | 211 | 0.020 |
Why?
|
Hospitalization | 2 | 2006 | 10790 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9185 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2002 | 3224 | 0.020 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2008 | 75 | 0.020 |
Why?
|
Thrombosis | 1 | 2002 | 3052 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2009 | 8986 | 0.020 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2008 | 144 | 0.020 |
Why?
|
Cholangiography | 1 | 2008 | 181 | 0.020 |
Why?
|
Electric Stimulation | 2 | 2006 | 1735 | 0.020 |
Why?
|
Critical Care | 1 | 2001 | 2699 | 0.020 |
Why?
|
Hospital Mortality | 3 | 2009 | 5425 | 0.020 |
Why?
|
Leukocytosis | 1 | 2009 | 251 | 0.020 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2008 | 125 | 0.020 |
Why?
|
Asthma | 1 | 2006 | 6172 | 0.020 |
Why?
|
Pennsylvania | 1 | 2008 | 615 | 0.020 |
Why?
|
Cerebrovascular Circulation | 3 | 2002 | 2733 | 0.020 |
Why?
|
Coproporphyrinogen Oxidase | 1 | 2006 | 5 | 0.020 |
Why?
|
Stroke Volume | 1 | 2001 | 5523 | 0.020 |
Why?
|
Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
Health Services for the Aged | 1 | 2009 | 259 | 0.020 |
Why?
|
Evaluation Studies as Topic | 2 | 1999 | 1628 | 0.020 |
Why?
|
Homocysteine | 1 | 2010 | 640 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2010 | 916 | 0.020 |
Why?
|
Nicotinic Agonists | 1 | 2009 | 265 | 0.020 |
Why?
|
Maine | 1 | 2006 | 145 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2009 | 578 | 0.020 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2008 | 231 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2009 | 713 | 0.020 |
Why?
|
Activities of Daily Living | 2 | 2008 | 2417 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 252 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.020 |
Why?
|
Coronary Artery Disease | 2 | 2010 | 6659 | 0.020 |
Why?
|
Marital Status | 1 | 2008 | 433 | 0.020 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2006 | 117 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1999 | 3804 | 0.020 |
Why?
|
Registries | 2 | 1999 | 8469 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2008 | 12531 | 0.020 |
Why?
|
Laparoscopy | 2 | 2009 | 2147 | 0.020 |
Why?
|
Pediatrics | 1 | 2001 | 3586 | 0.020 |
Why?
|
Methacholine Chloride | 1 | 2006 | 220 | 0.020 |
Why?
|
Protoporphyrins | 1 | 2006 | 165 | 0.020 |
Why?
|
Neoplasms | 2 | 2009 | 22072 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 1998 | 1919 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2008 | 348 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2002 | 3763 | 0.020 |
Why?
|
Developed Countries | 1 | 2009 | 442 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2007 | 339 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2002 | 4319 | 0.020 |
Why?
|
Risk | 3 | 2003 | 9631 | 0.020 |
Why?
|
Embryo Implantation | 2 | 1998 | 270 | 0.020 |
Why?
|
Attitude to Health | 2 | 2008 | 2029 | 0.020 |
Why?
|
Manometry | 1 | 2008 | 453 | 0.020 |
Why?
|
Cotinine | 1 | 2006 | 203 | 0.020 |
Why?
|
Crohn Disease | 1 | 1998 | 2275 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2008 | 506 | 0.020 |
Why?
|
Observer Variation | 2 | 2003 | 2601 | 0.020 |
Why?
|
Vital Capacity | 1 | 2008 | 965 | 0.020 |
Why?
|
Databases as Topic | 1 | 2007 | 474 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 2008 | 364 | 0.020 |
Why?
|
Guanylate Cyclase-Activating Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
Expert Testimony | 1 | 2008 | 361 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 412 | 0.020 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2004 | 65 | 0.020 |
Why?
|
Administration, Oral | 2 | 2003 | 4035 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2496 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5761 | 0.020 |
Why?
|
Spirometry | 1 | 2008 | 924 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 861 | 0.010 |
Why?
|
Parity | 1 | 2008 | 925 | 0.010 |
Why?
|
Computer Systems | 1 | 2006 | 470 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 2 | 1999 | 791 | 0.010 |
Why?
|
Disabled Persons | 2 | 2006 | 1223 | 0.010 |
Why?
|
Uncertainty | 1 | 2009 | 754 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 260 | 0.010 |
Why?
|
Video Recording | 1 | 2009 | 955 | 0.010 |
Why?
|
South Africa | 1 | 2009 | 1821 | 0.010 |
Why?
|
Hospitals, University | 1 | 2005 | 568 | 0.010 |
Why?
|
Clinical Chemistry Tests | 1 | 2003 | 59 | 0.010 |
Why?
|
Patient Readmission | 2 | 2008 | 3323 | 0.010 |
Why?
|
Health Resources | 1 | 2009 | 935 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2004 | 6498 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 2002 | 4899 | 0.010 |
Why?
|
Prone Position | 1 | 2004 | 196 | 0.010 |
Why?
|
Cyclic GMP | 1 | 2004 | 395 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 2006 | 743 | 0.010 |
Why?
|
Creatinine | 1 | 2009 | 1903 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2001 | 5351 | 0.010 |
Why?
|
Choice Behavior | 1 | 2009 | 821 | 0.010 |
Why?
|
Troponin T | 1 | 2008 | 774 | 0.010 |
Why?
|
Ambulances | 1 | 2003 | 92 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1440 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 1999 | 1529 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2009 | 1548 | 0.010 |
Why?
|
Electrocardiography | 2 | 2008 | 6414 | 0.010 |
Why?
|
Schizophrenia | 1 | 2001 | 6915 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2003 | 524 | 0.010 |
Why?
|
Telemedicine | 1 | 1999 | 3018 | 0.010 |
Why?
|
Embryo, Mammalian | 2 | 1998 | 1674 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2362 | 0.010 |
Why?
|
Forms and Records Control | 1 | 2002 | 158 | 0.010 |
Why?
|
Models, Statistical | 2 | 2007 | 5075 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2006 | 442 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4925 | 0.010 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2009 | 1004 | 0.010 |
Why?
|
Rehabilitation Centers | 1 | 2003 | 248 | 0.010 |
Why?
|
Disaster Planning | 1 | 2007 | 558 | 0.010 |
Why?
|
Prevalence | 3 | 2008 | 15687 | 0.010 |
Why?
|
Delphi Technique | 1 | 2005 | 829 | 0.010 |
Why?
|
Cell Biology | 1 | 2002 | 90 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2005 | 651 | 0.010 |
Why?
|
Oxygen | 2 | 2004 | 4193 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1156 | 0.010 |
Why?
|
Drug Synergism | 1 | 2005 | 1754 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2002 | 379 | 0.010 |
Why?
|
Laminectomy | 1 | 2002 | 224 | 0.010 |
Why?
|
Urinalysis | 1 | 2003 | 368 | 0.010 |
Why?
|
RNA, Viral | 1 | 2009 | 2838 | 0.010 |
Why?
|
Conscious Sedation | 1 | 2006 | 529 | 0.010 |
Why?
|
Referral and Consultation | 2 | 2007 | 3598 | 0.010 |
Why?
|
Total Quality Management | 1 | 2002 | 265 | 0.010 |
Why?
|
Capillaries | 1 | 2004 | 744 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2295 | 0.010 |
Why?
|
Estriol | 1 | 2000 | 51 | 0.010 |
Why?
|
Economics, Medical | 1 | 2001 | 112 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1999 | 9276 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2007 | 1797 | 0.010 |
Why?
|
Memory Disorders | 1 | 2008 | 1197 | 0.010 |
Why?
|
Allergy and Immunology | 1 | 2002 | 175 | 0.010 |
Why?
|
Neck | 1 | 2005 | 731 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2007 | 2435 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2003 | 532 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 2001 | 279 | 0.010 |
Why?
|
Cross-Sectional Studies | 3 | 2007 | 25942 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2000 | 223 | 0.010 |
Why?
|
Occupational Therapy | 1 | 2001 | 139 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 2003 | 805 | 0.010 |
Why?
|
Embolism | 1 | 2003 | 408 | 0.010 |
Why?
|
Educational Status | 1 | 2008 | 2515 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2004 | 1146 | 0.010 |
Why?
|
Form Perception | 1 | 2001 | 175 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 2000 | 66 | 0.010 |
Why?
|
Blood Volume | 1 | 2001 | 550 | 0.010 |
Why?
|
Neuromuscular Junction | 1 | 2002 | 406 | 0.010 |
Why?
|
Career Choice | 1 | 2006 | 754 | 0.010 |
Why?
|
Drug Interactions | 1 | 2004 | 1428 | 0.010 |
Why?
|
Benchmarking | 1 | 2006 | 1044 | 0.010 |
Why?
|
Ulnar Nerve | 1 | 2000 | 102 | 0.010 |
Why?
|
Cyclosporine | 1 | 2002 | 777 | 0.010 |
Why?
|
Paraplegia | 1 | 2000 | 162 | 0.010 |
Why?
|
Tumor Burden | 1 | 2005 | 1895 | 0.010 |
Why?
|
Waiting Lists | 1 | 2004 | 763 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2006 | 4360 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1347 | 0.010 |
Why?
|
Personnel, Hospital | 1 | 2001 | 285 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 8950 | 0.010 |
Why?
|
Patient Transfer | 1 | 2006 | 779 | 0.010 |
Why?
|
Fear | 1 | 2008 | 1462 | 0.010 |
Why?
|
Blood | 1 | 2001 | 586 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2005 | 2061 | 0.010 |
Why?
|
Spinal Cord Ischemia | 1 | 2000 | 94 | 0.010 |
Why?
|
Haloperidol | 1 | 2000 | 389 | 0.010 |
Why?
|
Hydrostatic Pressure | 1 | 1999 | 95 | 0.010 |
Why?
|
Ovulation Induction | 1 | 2001 | 277 | 0.010 |
Why?
|
Algorithms | 3 | 2006 | 13981 | 0.010 |
Why?
|
Gastric Emptying | 1 | 2001 | 243 | 0.010 |
Why?
|
Qualitative Research | 1 | 2009 | 2963 | 0.010 |
Why?
|
Health Benefit Plans, Employee | 1 | 2001 | 333 | 0.010 |
Why?
|
Maxilla | 1 | 2001 | 491 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 1999 | 158 | 0.010 |
Why?
|
Heart Valves | 1 | 2000 | 285 | 0.010 |
Why?
|
Dermatitis | 1 | 2000 | 200 | 0.010 |
Why?
|
Administration, Topical | 1 | 2000 | 697 | 0.010 |
Why?
|
Motivation | 1 | 2008 | 1993 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2375 | 0.010 |
Why?
|
Menotropins | 1 | 1998 | 41 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2000 | 881 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5877 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2008 | 1824 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2002 | 948 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1613 | 0.010 |
Why?
|
Posture | 1 | 2002 | 953 | 0.010 |
Why?
|
Motor Skills | 1 | 2001 | 520 | 0.010 |
Why?
|
Physical Therapy Modalities | 1 | 2001 | 536 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2005 | 6131 | 0.010 |
Why?
|
Hypertension | 2 | 2010 | 8594 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 2001 | 546 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2003 | 1577 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1166 | 0.010 |
Why?
|
Wakefulness | 1 | 2004 | 1255 | 0.010 |
Why?
|
Urography | 1 | 1998 | 312 | 0.010 |
Why?
|
Dental Implantation, Endosseous | 1 | 2001 | 528 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 1999 | 450 | 0.010 |
Why?
|
New York | 1 | 2000 | 875 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1880 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2005 | 2379 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4122 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 544 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2000 | 10827 | 0.010 |
Why?
|
Myeloblastin | 1 | 1997 | 101 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2394 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1098 | 0.010 |
Why?
|
Body Temperature | 1 | 2000 | 777 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6238 | 0.010 |
Why?
|
Follistatin | 1 | 1997 | 137 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2000 | 384 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2001 | 1130 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2001 | 875 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2002 | 1722 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 426 | 0.010 |
Why?
|
Demography | 1 | 2001 | 1650 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1999 | 956 | 0.010 |
Why?
|
Mullerian Ducts | 1 | 1997 | 201 | 0.010 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7475 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5797 | 0.010 |
Why?
|
Disorders of Sex Development | 1 | 1997 | 128 | 0.010 |
Why?
|
Developing Countries | 1 | 2009 | 2868 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2003 | 10344 | 0.010 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2000 | 517 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 1999 | 4541 | 0.010 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2000 | 479 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2009 | 3736 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 2003 | 1405 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 2001 | 11152 | 0.010 |
Why?
|
Communication | 1 | 2009 | 3849 | 0.010 |
Why?
|
Shoulder Joint | 1 | 2002 | 732 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 2272 | 0.010 |
Why?
|
Arthroscopy | 1 | 2002 | 960 | 0.010 |
Why?
|
Urban Population | 1 | 2003 | 2022 | 0.010 |
Why?
|
Bone Transplantation | 1 | 2000 | 922 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5508 | 0.010 |
Why?
|
Washington | 1 | 1996 | 312 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2001 | 1206 | 0.010 |
Why?
|
Tissue Donors | 1 | 2004 | 2313 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2629 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 7021 | 0.010 |
Why?
|
Sjogren's Syndrome | 1 | 1996 | 235 | 0.010 |
Why?
|
Reaction Time | 1 | 2001 | 2075 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 1997 | 407 | 0.010 |
Why?
|
Epithelium | 1 | 1999 | 1605 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2009 | 26181 | 0.010 |
Why?
|
Fertility | 1 | 1999 | 773 | 0.010 |
Why?
|
Palliative Care | 1 | 2009 | 3607 | 0.010 |
Why?
|
Rabbits | 1 | 2000 | 4773 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2000 | 820 | 0.010 |
Why?
|
Emergencies | 1 | 2001 | 1211 | 0.010 |
Why?
|
Calcium | 1 | 2007 | 5725 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 2001 | 1646 | 0.010 |
Why?
|
Hospitals | 1 | 2007 | 3928 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2006 | 3696 | 0.010 |
Why?
|
Testis | 1 | 1997 | 794 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1998 | 617 | 0.010 |
Why?
|
Dopamine | 1 | 2001 | 1595 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1900 | 0.010 |
Why?
|
Myositis | 1 | 1996 | 269 | 0.010 |
Why?
|
Self-Assessment | 1 | 1996 | 393 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 8035 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2002 | 4810 | 0.010 |
Why?
|
Knee Joint | 1 | 2002 | 1663 | 0.010 |
Why?
|
Cerebellum | 1 | 2001 | 1496 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8552 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2001 | 2210 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2001 | 1784 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1996 | 979 | 0.010 |
Why?
|
Cryopreservation | 1 | 1998 | 717 | 0.010 |
Why?
|
Patient Discharge | 1 | 2006 | 3476 | 0.010 |
Why?
|
Scleroderma, Systemic | 1 | 1996 | 344 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6180 | 0.010 |
Why?
|
Sweden | 1 | 1995 | 1381 | 0.010 |
Why?
|
Hysterectomy | 1 | 1998 | 904 | 0.010 |
Why?
|
Vasculitis | 1 | 1996 | 523 | 0.010 |
Why?
|
Research Support as Topic | 1 | 1996 | 699 | 0.010 |
Why?
|
Age of Onset | 1 | 1999 | 3301 | 0.010 |
Why?
|
Commerce | 1 | 1997 | 605 | 0.010 |
Why?
|
Allergens | 1 | 1999 | 1402 | 0.010 |
Why?
|
Forecasting | 1 | 2001 | 2932 | 0.010 |
Why?
|
Animals | 4 | 2005 | 167963 | 0.010 |
Why?
|
Radiography | 1 | 2002 | 6965 | 0.010 |
Why?
|
Cost of Illness | 1 | 2001 | 1940 | 0.010 |
Why?
|
Aging | 1 | 2010 | 8651 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2001 | 2554 | 0.010 |
Why?
|
Infertility | 1 | 1998 | 655 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10547 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10446 | 0.010 |
Why?
|
Urology | 1 | 1995 | 423 | 0.010 |
Why?
|
Estradiol | 1 | 1997 | 1932 | 0.010 |
Why?
|
Biopsy | 1 | 2002 | 6771 | 0.010 |
Why?
|
Probability | 1 | 1995 | 2475 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9501 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9467 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 6465 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2001 | 2622 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16939 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2005 | 8515 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1407 | 0.010 |
Why?
|
Body Weight | 1 | 2000 | 4611 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2006 | 11481 | 0.000 |
Why?
|
Health Expenditures | 1 | 2001 | 2362 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1999 | 5201 | 0.000 |
Why?
|
Critical Illness | 1 | 2001 | 2709 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11071 | 0.000 |
Why?
|
Sepsis | 1 | 2001 | 2592 | 0.000 |
Why?
|
Research | 1 | 1995 | 1974 | 0.000 |
Why?
|
Testosterone | 1 | 1997 | 2470 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1998 | 2003 | 0.000 |
Why?
|
Obesity | 1 | 2008 | 12922 | 0.000 |
Why?
|
Heart Failure | 1 | 2009 | 11847 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1996 | 2159 | 0.000 |
Why?
|
Body Mass Index | 1 | 2001 | 12914 | 0.000 |
Why?
|
Cognition | 1 | 2001 | 6957 | 0.000 |
Why?
|
Societies, Medical | 1 | 1995 | 3905 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7408 | 0.000 |
Why?
|
Clinical Competence | 1 | 1998 | 4783 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1998 | 4024 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13630 | 0.000 |
Why?
|
Arthritis, Rheumatoid | 1 | 1996 | 3763 | 0.000 |
Why?
|
Physicians | 1 | 1999 | 4591 | 0.000 |
Why?
|
Mice | 1 | 2005 | 81208 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 11712 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13262 | 0.000 |
Why?
|